Process Industries · Chemicals: Specialty · NSE: PAR · data 2026-10-09
Par Drugs and Chemicals Limited
Health check: Strong (6.7/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹117.1
Market cap
₹149 cr
P/E
9.9
P/B
—
ROE
12.4%
ROCE
12.1%
Debt / equity
0
Dividend yield
0.00%
1-year return
10.0%
52-week high
₹180
52-week low
₹78.05
Operating margin
14.9%
Growth
| Revenue (last 12 months) | ₹109 cr |
| Net profit (last 12 months) | ₹14 cr |
| Sales growth, 3 years (yearly) | 2.7% |
| Profit growth, 3 years (yearly) | 5.0% |
Similar companies
Signet Industries Limited (SIGIND) · Kanchi Karpooram Ltd (KANCHI) · Rajputana Biodiesel Limited (RAJPUTANA) · Hindprakash Industries Ltd. (HPIL) · Jocil Limited (JOCIL)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open PAR in NSE Scanner →